Here are the top drugs expected to be approved this year and their financial impact.
From breast cancer to prostate cancer, the state of oncology care and how it will evolve.
What to expect for these high-dollar drugs.
The vaccines that could make a big impact on healthcare, from radical new flu vaccines to simplified meningococcal vaccine regimens.
The disease management and insurer initiatives changing the diabetes landscape.
The latest in RA therapies, and what you can expect from the pipeline.
Managed Healthcare Executive asked top experts their predictions for the top game-changing therapies. Here’s what they said.
The biggest drug categories and medications set for approval this year.
Major blockbuster drugs slated for launch in 2019 are expected to have a significant impact on treating certain cancers, diabetes, peanut allergies, and other conditions.
In the past week, the migraine prevention drug market has suddenly heated up, with 2 new approvals by FDA.